(Q43610369)

25 November 2017

title

Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention (English)

1 reference

25 November 2017

J A Ambrose

1

1 reference

25 November 2017

R Doss

2

1 reference

25 November 2017

J M Geagea

3

1 reference

25 November 2017

M C Hawkey

4

1 reference

25 November 2017

S Duvuri

5

1 reference

25 November 2017

K Giedd

6

1 reference

25 November 2017

A Dominguez

7

1 reference

25 November 2017

J Coppola

8

1 reference

25 November 2017

T H Nguyen

9

1 reference

25 November 2017

V Palla

10

1 reference

25 November 2017

R S Barua

11

1 reference

25 November 2017

D C Saha

12

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

American Journal of Cardiology

25 November 2017

published in

1 reference

25 November 2017

volume

87

1 reference

25 November 2017

issue

10

1 reference

25 November 2017

page(s)

1231-3: A8

1 reference

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

Antithrombotic effects of Abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

In vivo demonstration of an antithrombin effect of abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

Rapid platelet-function assay: an automated and quantitative cartridge-based method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

Networking in the hemostatic system. Integrin alphaiibbeta3 binds prothrombin and influences its activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901506-5

10.1016/S0002-9149(01)01506-5

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference